{"id":404149,"date":"2020-12-21T19:17:13","date_gmt":"2020-12-22T00:17:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=404149"},"modified":"2020-12-21T19:17:13","modified_gmt":"2020-12-22T00:17:13","slug":"deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/","title":{"rendered":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n LOS ANGELES<\/span>, Dec. 21, 2020<\/span> \/PRNewswire\/ — The Schall Law Firm<\/a><\/u>, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Innate Pharma S.A. (“Innate” or “the Company”) (NASDAQ: IPHA) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b<\/span>-5 promulgated thereunder by the U.S. Securities and Exchange Commission.<\/p>\n

\n

DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A.<\/div>\n

Investors who purchased the Company’s securities between March 10, 2020<\/span> and September 8, 2020<\/span>, inclusive (the ”Class Period”), are encouraged to contact the firm before December 22, 2020<\/span>.<\/p>\n

If you are a shareholder who suffered a loss, click here to participate<\/a>.<\/p>\n

We also encourage you to contact Brian Schall<\/span> of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA<\/span> 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at\u00a0www.schallfirm.com<\/a><\/u>, or by email at\u00a0brian@schallfirm.com<\/a><\/u>.<\/p>\n

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. <\/p>\n

According to the Complaint, the Company made false and misleading statements to the market. Innate touted the results of its Phase 2 trials as meeting their expectations. The Company continued to promise investors that its results would make it eligible for a $100 million<\/span> payment upon beginning a Phase 3 trial. The Company failed to provide timely disclosure to the market regarding the renegotiation of its agreement with AstraZeneca for the $100 million<\/span> payment, which would split the total amount into two $50 million<\/span> payments contingent on performance. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Innate, investors suffered damages.<\/p>\n

\n Join the case<\/a>\u00a0to recover your losses.<\/p>\n

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.<\/p>\n

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.<\/p>\n

\u00a0<\/p>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-sa-and-encourages-investors-with-losses-in-excess-of-100-000-to-contact-the-firm-301197161.html<\/a><\/p>\n

SOURCE The Schall Law Firm<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire LOS ANGELES, Dec. 21, 2020 \/PRNewswire\/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Innate Pharma S.A. (“Innate” or “the Company”) (NASDAQ: IPHA) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. Investors who purchased the Company’s securities between March 10, 2020 and September 8, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before December 22, 2020. If you are a shareholder who suffered a loss, click here to participate. … <\/p>\n

Continue reading “DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-404149","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire LOS ANGELES, Dec. 21, 2020 \/PRNewswire\/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Innate Pharma S.A. (“Innate” or “the Company”) (NASDAQ: IPHA) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. Investors who purchased the Company’s securities between March 10, 2020 and September 8, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before December 22, 2020. If you are a shareholder who suffered a loss, click here to participate. … Continue reading "DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-22T00:17:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\",\"datePublished\":\"2020-12-22T00:17:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/\"},\"wordCount\":405,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA31320&sd=2020-12-21\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/\",\"name\":\"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA31320&sd=2020-12-21\",\"datePublished\":\"2020-12-22T00:17:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA31320&sd=2020-12-21\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=LA31320&sd=2020-12-21\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","og_description":"PR Newswire LOS ANGELES, Dec. 21, 2020 \/PRNewswire\/ — The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against\u00a0Innate Pharma S.A. (“Innate” or “the Company”) (NASDAQ: IPHA) for violations of \u00a7\u00a710(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. Investors who purchased the Company’s securities between March 10, 2020 and September 8, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before December 22, 2020. If you are a shareholder who suffered a loss, click here to participate. … Continue reading \"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-22T00:17:13+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm","datePublished":"2020-12-22T00:17:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/"},"wordCount":405,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/","name":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21","datePublished":"2020-12-22T00:17:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=LA31320&sd=2020-12-21"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/deadline-tomorrow-the-schall-law-firm-announces-the-filing-of-a-class-action-lawsuit-against-innate-pharma-s-a-and-encourages-investors-with-losses-in-excess-of-100000-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Innate Pharma S.A. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=404149"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/404149\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=404149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=404149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=404149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}